Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04201782 · ClinicalTrials.gov registry record
Long-term Follow-up of HIV Subjects Exposed to SB-728-T or SB-728mR-T
A clinical trial, sponsored by Sangamo Therapeutics.
- Terminated
- Registry status
- 38
- Enrollment target
NCT04201782 is a clinical trial that was terminated before completion, run by Sangamo Therapeutics. The registered enrollment target is 38 participants.
The verdict
NCT04201782 was terminated before completion, sponsored by Sangamo Therapeutics.
- TERMINATED
- Registry status
- 38 participants
- Enrollment target
Study Summary
Long-term follow-up of HIV-infected subjects who received SB-728-T or SB-728mR-T. Enrolling subjects will be followed for a total of 12 years.
Interventions
- DRUG There are no disallowed treatments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2011-03-18 |
| Est. Completion | 2023-07-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04201782
The ClinicalTrials.gov registry entry for NCT04201782 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sangamo Therapeutics, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which There are no disallowed treatments is the first listed.
NCT04201782 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04201782 about?
NCT04201782 is a clinical study titled "Long-term Follow-up of HIV Subjects Exposed to SB-728-T or SB-728mR-T". Long-term follow-up of HIV-infected subjects who received SB-728-T or SB-728mR-T. Enrolling subjects will be followed for a total of 12 years.
What is the current status of trial NCT04201782?
This trial is currently terminated. The enrollment target is 38 participants. The study started on 2011-03-18. Estimated completion is 2023-07-17.
What interventions are being tested in trial NCT04201782?
The interventions under investigation include: There are no disallowed treatments (DRUG).
Who is sponsoring clinical trial NCT04201782?
This trial is sponsored by Sangamo Therapeutics, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.